Amanda Noel Hatzenbuehler, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2707 L St, Ord, NE 68862 Phone: 908-728-4223 |
Traci Marie Fahrenholz, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 320 N 19th St, Ord, NE 68862 Phone: 308-728-5013 |
Hallelujah Ruth Yantzie, Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 2707 L St, Ord, NE 68862 Phone: 083-728-4200 Fax: 308-728-3500 |
Mrs. Jenna Jo Breitkreutz, RN Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 320 N 19th St, Ord, NE 68862 Phone: 308-728-3331 |
News Archive
Bayer HealthCare Pharmaceuticals announced today that an orphan drug designation has been granted by the U.S. Food and Drug Administration for ciprofloxacin dry powder inhaler for management of pulmonary infection due to Pseudomonas aeruginosa in cystic fibrosis patients. A similar designation has already been granted by the European Medicines Agency.
Scientists at Forsyth, along with a colleague from Northwestern University, have discovered that the protein, Transgultaminase 2 (TG2), is a key component in the process of gum disease. TG2 is widely distributed inside and outside of human cells. The scientists found that blocking some associations of TG2 prevents the bacteria Porphyromonas gingivalis (PG) from adhering to cells. This insight may one day help lead to novel therapies to prevent gum disease caused by PG.
In regions where cancer survival is poorer, people on average have lower awareness of cancer symptoms, according to new findings published today (Wednesday) in the British Journal of Cancer.
As part of the Administration's ongoing efforts to strengthen cybersecurity in health care, the U.S. Food and Drug Administration and the U.S. Department of Homeland Security (DHS) announced a memorandum of agreement to implement a new framework for greater coordination and cooperation between the two agencies for addressing cybersecurity in medical devices.
› Verified 5 days ago